Mr. Speaker, those are excellent questions and I know the member for Yukon has shared these views very passionately.
The example is that the United States, which of course is home to many of the national brand name manufacturers for which Canada is home to none except for the warehouses and our generic industry, has already demonstrated that this abuse must stop. Senator McCain and Senator Schumer led the charge in the United States. In Canada our industry committee tried to do the same. Unfortunately there seems to be a deliberate attempt not to try to tackle the real issues.
I know the hon. member finds this interesting. There are some in this House who may want to suggest that generic drugs are more expensive in Canada than anywhere else in the world. They are 400% less in Canada than they are in the United States after we take into account the difference in the dollar valuation. That is as a result of what happened 20 to 30 years ago when we brought in the ability for compulsory licensing.
It is very clear that Canada remains the only nation in the world, after this floor order goes into place, that has automatic injunctions which costs everybody. We have to stop be the world's international thumb-sucking dolts on this one.